PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory for diagnosis and treatment of infectious diseases, Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.\', \'State Key Laboratory for diagnosis and treatment of infectious diseases, Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Electronic address: qiuyq@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0928-0987(20)30419-X10.1016/j.ejps.2020.105631
?:hasPublicationType
?:journal
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
is ?:pmid of
?:pmid
?:pmid
  • 33115675
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all